![Perenlei Enkhbaatar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perenlei Enkhbaatar is currently the Director-Translational Intensive Care & Professor at the University of Texas Medical Branch At Galveston.
Previously, Dr. Enkhbaatar served as an Independent Director at Claritas Pharmaceuticals, Inc. Dr. Enkhbaatar holds a doctorate degree from the Graduate School of Medical Sciences Kumamoto University.
| Sociétés | Poste | Début |
|---|---|---|
University of Texas Medical Branch At Galveston
 University of Texas Medical Branch At Galveston Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| CLARITAS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Claritas Pharmaceuticals, Inc.
 Claritas Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops and commercializes therapies for patients | Health Technology |
University of Texas Medical Branch At Galveston
University of Texas Medical Branch At Galveston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graduate School of Medical Sciences Kumamoto University
 Graduate School of Medical Sciences Kumamoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
